Complete Filing Data
InflaRx N.V. reported Cash And Cash Equivalents of $16.02 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean InflaRx N.V. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Research And Development Expense | $25.7M | $35.4M | $41.0M | $37.5M | $35.7M | $25.7M | $44.6M | $25.0M | $14.4M | $5.3M | $3.5M |
| Profit Loss | -$45.6M | -$46.1M | -$42.7M | -$29.5M | -$45.6M | -$34.0M | -$53.3M | -$29.8M | -$24.2M | -$8.9M | -$4.9M |
| Comprehensive Income | -$45.9M | -$46.0M | -$42.5M | -$25.3M | -$38.9M | -$39.9M | -$51.1M | -$29.8M | -$24.2M | -$8.9M | -$4.9M |
| Revenue And Operating Income | -$48.3M | -$53.0M | -$44.9M | -$32.2M | -$37.5M | -$19.4M | -$6.9M | ||||
| Selling General And Administrative Expense | $14.9M | $12.0M | $8.5M | $12.5M | $12.8M | $5.1M | $1.8M | $438.0K | |||
| Gross Profit | -$7.2M | -$3.2M | -$469.2K | -$37.8M | -$19.6M | -$7.1M | |||||
| Profit Loss Before Tax | -$34.0M | -$53.3M | -$29.8M | -$24.2M | -$8.9M | -$4.9M | |||||
| General And Administrative Expense | $13.5M | $13.0M | $12.6M | $14.9M | $12.0M | ||||||
| Other Comprehensive Income Net Of Tax Exchange Differences On Translation Other Than Translation Of Foreign Operations | -$269.1K | $58.3K | $125.1K | $4.2M | $6.8M | ||||||
| Sales And Marketing Expense | $4.5M | $6.8M | $4.0M | ||||||||
| Income Tax Expense Continuing Operations | $12.3K | $5.2K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | $16.0M | $18.4M | $12.8M | $16.3M | $26.2M | $26.0M | $33.1M | $55.4M | $123.3M | $29.1M | $3.3M | $6.6M |
| Cash Flows From Used In Operating Activities | -$35.3M | -$48.6M | -$37.8M | -$33.7M | -$39.9M | -$36.5M | -$43.2M | -$21.5M | -$12.2M | -$5.0M | -$3.3M | |
| Cash Flows From Used In Investing Activities | $3.2M | $52.4M | -$17.7M | $19.4M | -$26.0M | $21.4M | $20.3M | -$99.4M | -$167.0K | -$53.0K | -$13.0K | |
| Cash Flows From Used In Financing Activities | $33.3M | $386.4K | $53.0M | $1.9M | $61.6M | $9.2M | -$294.3K | $49.6M | $108.8M | $30.9M | $0.00 | |
| Adjustments For Increase Decrease In Employee Benefit Liabilities | -$900.4K | $454.9K | $297.5K | -$64.0K | -$3.3K | $355.5K | $235.5K | $494.8K | $132.3K | $113.0K | ||
| Adjustments For Decrease Increase In Other Current Assets | $2.2M | $1.0M | $7.8M | -$3.3M | -$7.1M | -$1.6M | -$82.6M | -$316.1K | $89.6K | -$74.0K | ||
| Trade And Other Current Payables | $5.4M | $11.4M | $12.0M | $5.0M | $8.6M | $8.3M | $12.4M | $6.7M | $4.5M | $1.5M | ||
| Retained Earnings | -$377.8M | -$332.2M | -$286.1M | -$243.5M | -$214.0M | -$168.3M | -$134.4M | -$81.1M | -$51.3M | -$27.1M | ||
| Noncurrent Liabilities | $677.9K | $435.9K | $782.6K | $1.0M | $1.1M | $253.8K | $369.8K | $67.9K | $17.0K | $53.5M | ||
| Noncurrent Assets | $1.6M | $4.4M | $10.7M | $5.0M | $29.5M | $1.9M | $2.6M | $1.1M | $234.0K | $137.0K | ||
| Equity And Liabilities | $55.2M | $76.0M | $120.2M | $102.4M | $125.1M | $88.2M | $121.6M | $159.2M | $124.2M | $29.5M | ||
| Current Liabilities | $13.0M | $14.2M | $16.8M | $13.0M | $18.8M | $10.1M | $14.1M | $7.8M | $4.8M | $1.7M | ||
| Current Assets | $53.6M | $71.7M | $109.5M | $97.4M | $95.7M | $86.3M | $119.0M | $158.2M | $124.0M | $29.4M | ||
| Assets | $55.2M | $76.0M | $120.2M | $102.4M | $125.1M | $88.2M | $121.6M | $159.2M | $124.2M | $29.5M | ||
| Property Plant And Equipment | $289.3K | $256.3K | $289.6K | $328.9K | $274.4K | $408.3K | $576.4K | $624.7K | $173.0K | |||
| Liabilities | $13.7M | $14.6M | $17.6M | $14.1M | $19.9M | $10.4M | $14.4M | $7.8M | $4.8M | |||
| Adjustments For Increase Decrease In Trade Account Payable | $316.1K | -$4.2M | $5.7M | $2.2M | $2.9M | $1.2M | $389.0K | |||||
| Adjustments For Increase Decrease In Other Liabilities | $57.4K | -$2.6M | $2.7M | $9.4K | $19.9K | $9.0K | -$209.9K | $304.6K | ||||
| Current Lease Liabilities | $256.9K | $406.0K | $374.3K | $369.4K | $366.2K | $338.5K | $515.2K | $0.00 | ||||
| Rightofuse Assets | $861.7K | $758.4K | $1.1M | $1.3M | $1.4M | $546.7K | $836.9K | |||||
| Purchase Of Intangible Assets Classified As Investing Activities | -$37.8K | -$94.2K | -$594.9K | $806.5K | $148.5K | $53.0K | $13.0K | |||||
| Other Noncurrent Financial Assets | $272.3K | $272.6K | $207.4K | $20.0K | $1.0K | |||||||
| Noncurrent Lease Liabilities | $641.0K | $399.1K | $745.7K | $987.3K | $1.1M | $220.5K | $330.7K | $0.00 | ||||
| Other Current Liabilities | $359.0K | $301.5K | $2.9M | $147.6K | $138.2K | $117.7K | ||||||
| Purchase Of Property Plant And Equipment Intangible Assets Other Than Goodwill Investment Property And Other Noncurrent Assets | $115.7K | $46.9K | $81.1K | $162.4K | $37.8K | $94.2K | ||||||
| Intangible Assets Other Than Goodwill | $138.9K | $235.2K | $350.2K | $452.4K | $222.9K | $41.0K | $5.0K | |||||
| Expense From Equitysettled Sharebased Payment Transactions In Which Goods Or Services Received Did Not Qualify For Recognition As Assets | $12.1M | $4.6M | $868.0K | $242.0K | ||||||||
| Other Current Assets | $3.3M | $5.1M | $4.0M | $14.2M | $11.0M | $3.7M | ||||||
| Current Financial Assets | $733.0K | $57.2M | $55.2M | $82.4M | $101.2M | $0.00 | ||||||
| Adjustments For Increase Decrease In Trade And Other Payables | -$6.0M | -$580.1K | $7.0M | -$3.6M | $316.1K | -$4.2M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | -$3.6M | $1.4M | -$974.1K | $2.5M | $4.6M | -$1.2M | $902.3K | $3.5M | -$2.3M | $1.0K | $1.0K |
| Increase Decrease In Cash And Cash Equivalents | $1.2M | $4.2M | -$2.5M | -$12.4M | -$4.3M | -$6.0M | -$23.2M | -$71.4M | $94.2M | $25.8M | |
| Proceeds From Exercise Of Options | $236.9K | $1.0M | $496.9K | $1.7K | $452.1K | $0.00 | |||||
| Proceeds From Disposal Or Maturity Of Availableforsale Financial Assets | $86.4M | $84.0M | $71.6M | $123.1M | $103.6M | $8.0M | |||||
| Proceeds From Disposal Of Noncurrent Other Financial Assets | $0.00 | $0.00 | $21.8K | $0.00 | $0.00 | ||||||
| Proceeds From Issuing Shares | 22.9M | 1.1M | 56.5M | 2.3M | 65.1M | 9.8M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Diluted Earnings Loss Per Share | $-0.68 | $-0.78 | $-0.78 | $-0.67 | $-1.10 | $-1.26 | $-1.19 | $-2.60 | $-3.80 | |
| Basic Earnings Loss Per Share | $-0.68 | $-0.78 | $-0.78 | $-0.67 | $-1.10 | $-1.26 | $-1.19 | $-2.60 | $-3.80 | |
| Weighted Average Shares | 67.3M | 58.9M | 54.9M | 44.2M | 41.6M | 27.1M | 26.0M | |||
| Adjusted Weighted Average Shares | 27.1M | 26.0M | 25.1M | 9.4M | 2.4K |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Finance Income | $1.8M | $3.2M | $3.8M | $608.7K | $109.4K | $887.7K | $2.8M | $2.2M | $130.0K | $1.0K | $5.0K |
| Finance Costs | $39.2K | $20.7K | $35.6K | $45.3K | $24.8K | $26.0K | -$22.3K | $0.00 | $4.9M | $2.0M | $1.1M |
| Other Income | $2.7M | $5.3M | $13.2M | $20.2M | $54.2K | $221.7K | $400.3K | $303.9K | $115.5K | $238.0K | |
| Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss | -$4.9M | $3.7M | -$1.8M | $2.4M | $2.0M | -$776.5K | $2.2M | $50.2K | $0.00 | $1.0K | $2.0K |
| Interest Received Classified As Operating Activities | $1.7M | $2.2M | $1.7M | $1.3M | $1.1M | $1.2M | $3.0M | $1.7M | $66.4K | $0.00 | $0.00 |
| Interest Paid Classified As Operating Activities | $34.5K | $21.1K | $36.0K | $44.9K | $23.6K | $26.4K | -$20.9K | $0.00 | $0.00 | $212.0K | -$5.0K |
| Adjustments For Finance Income Cost | $2.6M | $6.9M | $2.2M | $2.8M | $2.0M | -$40.8K | -$3.5M | $7.7M | -$4.8M | -$2.0M | -$1.1M |
| Share Issue Related Cost | $1.3M | $323.7K | $3.4M | $47.7K | $4.2M | $729.8K | $0.00 | -$3.8M | -$9.1M | $0.00 | $0.00 |
| Increase Decrease Through Sharebased Payment Transactions | $4.4M | $4.1M | $3.4M | $6.0M | $4.3M | $1.1M | $6.8M | $12.1M | $4.6M | $868.0K | |
| Adjustments For Depreciation Expense | $419.5K | $485.1K | $567.8K | $596.6K | $669.4K | $712.7K | $663.2K | $173.6K | $70.9K | $33.0K | $40.0K |
| Other Finance Income Cost | $5.7M | $103.3K | $313.2K | -$252.5K | -$44.0K | -$126.0K | $0.00 | -$107.2K | |||
| Gains Losses On Exchange Differences On Translation Net Of Tax | -$269.1K | $58.3K | $125.1K | $4.2M | $6.8M | -$6.0M | $2.2M | $50.2K | $0.00 | ||
| Other Reserves | $48.6M | $44.1M | $40.1M | $36.6M | $30.6M | $26.3M | $25.1M | $18.3M | $6.2M | $1.7M | |
| Issued Capital | $8.7M | $7.1M | $7.1M | $5.4M | $5.3M | $3.4M | $3.1M | $3.1M | $2.9M | $31.0K | |
| Share Premium | $355.0M | $334.9M | $334.2M | $282.6M | $280.3M | $220.3M | $211.0M | $211.0M | $161.6M | ||
| Repayments Of Borrowings Classified As Financing Activities | $357.6K | $388.1K | $374.0K | $364.4K | $360.6K | $366.2K | -$296.0K | $0.00 | $0.00 | ||
| Other Expense By Nature | $1.4K | $6.4K | $13.2K | $85.2K | $4.8K | $7.6K | $7.0K | ||||
| Adjustments For Unrealised Foreign Exchange Losses Gains | $1.5M | -$37.1K | $413.0K | $385.4K | $111.6K | -$247.3K | -$368.5K | -$17.3K | |||
| Other Adjustments For Noncash Items | $0.00 | $3.4K | $60.6K | $214.0K | $24.1K | -$2.0K | $0.00 | ||||
| Increase Decrease Through Exercise Of Options | $236.9K | $1.0M | $496.9K | $1.7K | $452.1K | ||||||
| Current Provisions For Employee Benefits | $1.2M | $2.1M | $1.6M | $1.3M | $1.4M | $1.4M | $975.6K | $789.8K | $295.0K | ||
| Issued Share Capital | -$9.8M | $0.00 | -$53.0M | -$90.9M | $0.00 | $0.00 | |||||
| Operating Expense | $52.4M | $47.7M | $34.2M | $57.1M | $37.8M | $19.6M | |||||
| Adjustments For Sharebased Payments | $4.4M | $4.1M | $3.4M | $6.0M | $4.3M | $1.1M | |||||
| Provisions | $0.00 | $15.0K | $50.0K | $0.00 | $2.0K | $2.0K | |||||
| Net Financial Result | $3.5M | $7.7M | -$4.8M | -$2.0M | |||||||
| Transaction Costs From Issuance Of Common Shares | 2.1M | 323.7K | 3.4M | 47.7K | 4.2M | 729.8K |
Most recent annual filing with the SEC: March 20, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.